2.7.7.40	Muscular Diseases	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31375477&form=6&db=m	Cytidine Diphosphate-Ribitol Analysis for Diagnostics and Treatment Monitoring of Cytidine Diphosphate-L-Ribitol Pyrophosphorylase A Muscular Dystrophy.	causal interaction,diagnostic usage,therapeutic application,unassigned	1,3,3,0	
2.7.7.40	Muscular Dystrophies	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31375477&form=6&db=m	Cytidine Diphosphate-Ribitol Analysis for Diagnostics and Treatment Monitoring of Cytidine Diphosphate-L-Ribitol Pyrophosphorylase A Muscular Dystrophy.	causal interaction,diagnostic usage,therapeutic application,unassigned	1,3,3,0	
2.7.7.40	Muscular Dystrophies	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34307571&form=6&db=m	Homozygous deletion, c. 1114-1116del, in exon 8 of the CRPPA gene causes congenital muscular dystrophy in Chinese family: A case report.	causal interaction,unassigned	1,0	
2.7.7.40	Muscular Dystrophies, Limb-Girdle	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31375477&form=6&db=m	Cytidine Diphosphate-Ribitol Analysis for Diagnostics and Treatment Monitoring of Cytidine Diphosphate-L-Ribitol Pyrophosphorylase A Muscular Dystrophy.	causal interaction,diagnostic usage,therapeutic application,unassigned	1,3,3,0	
2.7.7.40	Walker-Warburg Syndrome	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31375477&form=6&db=m	Cytidine Diphosphate-Ribitol Analysis for Diagnostics and Treatment Monitoring of Cytidine Diphosphate-L-Ribitol Pyrophosphorylase A Muscular Dystrophy.	causal interaction,diagnostic usage,therapeutic application,unassigned	1,3,3,0	
2.7.7.40	Walker-Warburg Syndrome	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33977792&form=6&db=m	Analysis of genotype-phenotype correlation in Walker-Warburg syndrome with a novel CRPPA mutation in different clinical manifestations.	causal interaction,unassigned	3,0